Total Payments
$124,329
2024 Payments
$613.31
Companies
12
Transactions
157
Medicare Patients
498
Medicare Billing
$106,844
Payment Breakdown by Category
Other$70,100 (56.4%)
Travel$33,831 (27.2%)
Consulting$12,535 (10.1%)
Education$4,534 (3.6%)
Food & Beverage$3,328 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,200 | 16 | 29.9% |
| Travel and Lodging | $33,831 | 49 | 27.2% |
| Honoraria | $32,900 | 13 | 26.5% |
| Consulting Fee | $12,535 | 8 | 10.1% |
| Education | $4,534 | 7 | 3.6% |
| Food and Beverage | $3,328 | 64 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $40,134 | 52 | $0 (2018) |
| DAVOL INC. | $29,078 | 40 | $0 (2018) |
| Neomend, Inc. | $27,207 | 21 | $0 (2017) |
| Clovis Oncology, Inc. | $14,088 | 18 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $7,406 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,615 | 3 | $0 (2024) |
| Seagen Inc. | $1,575 | 1 | $0 (2022) |
| Amgen Inc. | $56.25 | 3 | $0 (2018) |
| Intuitive Surgical, Inc. | $52.31 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $51.32 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $613.31 | 3 | AstraZeneca Pharmaceuticals LP ($525.00) |
| 2023 | $6,783 | 4 | GlaxoSmithKline, LLC. ($4,550) |
| 2022 | $1,575 | 1 | Seagen Inc. ($1,575) |
| 2021 | $1,665 | 1 | AstraZeneca Pharmaceuticals LP ($1,665) |
| 2018 | $26,856 | 48 | TESARO, Inc. ($10,729) |
| 2017 | $86,836 | 100 | TESARO, Inc. ($29,405) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Education | In-kind items and services | $64.50 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: Oncology | ||||||
| 07/04/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: Oncology | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 10/13/2022 | Seagen Inc. | TIVDAK (Biological) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: Oncology | ||||||
| 01/19/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| Category: Oncology | ||||||
| 12/03/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Oncology | ||||||
| 11/28/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Oncology | ||||||
| 11/19/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 11/14/2018 | TESARO, Inc. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2018 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 09/24/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Oncology | ||||||
| 07/24/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Oncology | ||||||
| 07/19/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 07/19/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $15.26 | General |
| Category: Oncology | ||||||
| 07/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $462.10 | General |
| Category: Oncology | ||||||
| 07/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $309.90 | General |
| Category: Oncology | ||||||
| 07/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $235.15 | General |
| Category: Oncology | ||||||
| 07/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $111.92 | General |
| Category: Oncology | ||||||
| 05/24/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 111 | 245 | $95,592 | $23,249 |
| 2022 | 4 | 121 | 273 | $52,103 | $27,058 |
| 2021 | 5 | 122 | 249 | $72,754 | $33,901 |
| 2020 | 4 | 144 | 241 | $63,363 | $22,636 |
Total Patients
498
Total Services
1,008
Medicare Billing
$106,844
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 34 | 154 | $65,450 | $16,251 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 44 | $12,804 | $3,214 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $12,280 | $2,740 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 27 | $5,058 | $1,043 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 38 | 174 | $36,130 | $19,080 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 52 | $6,998 | $3,588 | 51.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 22 | 22 | $6,632 | $3,127 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 25 | $2,343 | $1,263 | 53.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 37 | 155 | $28,055 | $17,844 | 63.6% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 13 | 13 | $33,754 | $9,403 | 27.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $4,640 | $2,792 | 60.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 31 | $3,875 | $2,306 | 59.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 30 | $2,430 | $1,556 | 64.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 106 | $33,072 | $11,264 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 56 | $13,048 | $4,504 | 34.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $7,031 | $2,624 | 37.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 18 | 27 | $4,887 | $2,419 | 49.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 25 | $3,950 | $1,209 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 11 | 11 | $1,375 | $616.03 | 44.8% |
About John Mcdonald
John Mcdonald is a Obstetrics healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467496869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Mcdonald has received a total of $124,329 in payments from pharmaceutical and medical device companies, with $613.31 received in 2024. These payments were reported across 157 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,200).
As a Medicare-enrolled provider, Mcdonald has provided services to 498 Medicare beneficiaries, totaling 1,008 services with total Medicare billing of $106,844. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics
- Other Specialties Gynecologic Oncology
- Location Charlotte, NC
- Active Since 06/15/2006
- Last Updated 08/19/2021
- Taxonomy Code 207VX0000X
- Entity Type Individual
- NPI Number 1467496869
Products in Payments
- DAV-Arista AH (Device) $51,362
- ZEJULA (Drug) $40,113
- Rubraca (Drug) $14,088
- LYNPARZA (Drug) $7,386
- ARISTA AH (Device) $4,924
- JEMPERLI (Biological) $1,950
- TIVDAK (Biological) $1,575
- Neulasta (Biological) $56.25
- Da Vinci Surgical System (Device) $52.31
- Lenvima (Drug) $37.18
- KEYTRUDA (Biological) $31.36
- XARELTO (Drug) $27.64
- LYNPARZA (Biological) $19.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics Doctors in Charlotte
Angelica Glover, M.d, M.D
Obstetrics — Payments: $1,480
Obstetrics $1,480
Monica Modi
Obstetrics — Payments: $668.91
Obstetrics $668.91
Scott Makemson, Md, MD
Obstetrics — Payments: $254.98
Obstetrics $254.98
Vasiliki Orfanakos
Obstetrics — Payments: $194.46
Obstetrics $194.46
Tyler Pierce, Md, MD
Obstetrics — Payments: $144.52
Obstetrics $144.52
Mrs. Trisha Dmytruk, Fnp, FNP
Obstetrics
Obstetrics